These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11374859)
1. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Kwiterovich PO Am J Cardiol; 2000 Dec; 86(12A):5L-10L. PubMed ID: 11374859 [TBL] [Abstract][Full Text] [Related]
2. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans. Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454 [TBL] [Abstract][Full Text] [Related]
3. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
4. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
5. [Lipoprotein metabolism]. Corvilain B Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients. Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282 [TBL] [Abstract][Full Text] [Related]
7. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice. Degrace P; Moindrot B; Mohamed I; Gresti J; Clouet P Atherosclerosis; 2006 Dec; 189(2):328-35. PubMed ID: 16487531 [TBL] [Abstract][Full Text] [Related]
8. The antiatherogenic role of high-density lipoprotein cholesterol. Kwiterovich PO Am J Cardiol; 1998 Nov; 82(9A):13Q-21Q. PubMed ID: 9819099 [TBL] [Abstract][Full Text] [Related]
9. Factorial experiment to determine influence of fish protein and fish oil on serum and liver lipids in rabbits. Bergeron N; Deshaies Y; Jacques H Nutrition; 1992; 8(5):354-8. PubMed ID: 1421781 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl. Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129 [TBL] [Abstract][Full Text] [Related]